Latest Insider Transactions at Accenture PLC (ACN)
This section provides a real-time view of insider transactions for Accenture PLC (ACN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Accenture plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Accenture plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
872
+5.3%
|
$173,528
$199.46 P/Share
|
|
Dec 05
2019
|
Simon Eaves Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct |
371
+4.32%
|
$73,829
$199.46 P/Share
|
|
Dec 05
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
905
+4.55%
|
$180,095
$199.46 P/Share
|
|
Dec 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,128
+4.68%
|
$224,472
$199.46 P/Share
|
|
Dec 05
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
113
+0.21%
|
$22,487
$199.46 P/Share
|
|
Dec 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+6.7%
|
$414,517
$199.46 P/Share
|
|
Dec 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,282
+6.46%
|
$255,118
$199.46 P/Share
|
|
Dec 05
2019
|
Joel Unruch General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
737
+3.0%
|
$146,663
$199.46 P/Share
|
|
Dec 05
2019
|
John F Walsh Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
909
+3.58%
|
$180,891
$199.46 P/Share
|
|
Nov 15
2019
|
Jaime Ardila Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.08%
|
-
|
|
Nov 15
2019
|
Gianfranco Casati CEO-Growth Markets |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.32%
|
-
|
|
Nov 15
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8
-0.05%
|
$1,568
$196.69 P/Share
|
|
Nov 15
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.51%
|
-
|
|
Nov 15
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49
-0.07%
|
$9,604
$196.69 P/Share
|
|
Nov 15
2019
|
Johan Deblaere Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.12%
|
-
|
|
Nov 15
2019
|
Simon Eaves Group Chief Executive-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
5
-0.06%
|
$980
$196.69 P/Share
|
|
Nov 15
2019
|
Simon Eaves Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.47%
|
-
|
|
Nov 15
2019
|
James O Etheredge Chief Exec-North America |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.05%
|
$1,764
$196.69 P/Share
|
|
Nov 15
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.18%
|
-
|
|
Nov 15
2019
|
Herbert Hainer Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.16%
|
-
|
|
Nov 15
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.11%
|
$6,272
$196.69 P/Share
|
|
Nov 15
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.32%
|
-
|
|
Nov 15
2019
|
Marjorie Magner Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.07%
|
-
|
|
Nov 15
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.05%
|
-
|
|
Nov 15
2019
|
Nancy Mc Kinstry Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.18%
|
-
|
|
Nov 15
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
6
-0.01%
|
$1,176
$196.69 P/Share
|
|
Nov 15
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.05%
|
-
|
|
Nov 15
2019
|
Jean Marc Ollagnier CEO EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
36
-0.02%
|
$7,056
$196.69 P/Share
|
|
Nov 15
2019
|
Jean Marc Ollagnier CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
92
+0.05%
|
-
|
|
Nov 15
2019
|
Gilles Pelisson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.11%
|
-
|
|
Nov 15
2019
|
Paula A Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.09%
|
-
|
|
Nov 15
2019
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-0.15%
|
$9,996
$196.69 P/Share
|
|
Nov 15
2019
|
David Rowland Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
112
+0.34%
|
-
|
|
Nov 15
2019
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.11%
|
-
|
|
Nov 15
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30
-0.11%
|
$5,880
$196.69 P/Share
|
|
Nov 15
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80
+0.3%
|
-
|
|
Nov 15
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49
-0.28%
|
$9,604
$196.69 P/Share
|
|
Nov 15
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
158
+0.9%
|
-
|
|
Nov 15
2019
|
Frank Kui Tang Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.1%
|
-
|
|
Nov 15
2019
|
Tracey Thomas Travis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.21%
|
-
|
|
Nov 15
2019
|
Joel Unruch General Counsel/Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4
-0.02%
|
$784
$196.69 P/Share
|
|
Nov 15
2019
|
Joel Unruch General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.19%
|
-
|
|
Nov 15
2019
|
John F Walsh Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.04%
|
-
|
|
Nov 15
2019
|
John F Walsh Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39
+0.17%
|
$7,644
$196.69 P/Share
|
|
Nov 15
2019
|
Venkata S M Renduchintala Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.26%
|
-
|
|
Nov 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109
+0.74%
|
$20,274
$186.74 P/Share
|
|
Nov 05
2019
|
Simon Eaves Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.83%
|
$12,090
$186.74 P/Share
|
|
Nov 05
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.72%
|
$24,180
$186.74 P/Share
|
|
Nov 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
141
+0.48%
|
$26,226
$186.74 P/Share
|
|
Nov 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.4%
|
$16,182
$186.74 P/Share
|